For instance, it is also approved for the treatment of polycystic ovary syndrome, and its regulatory action on the mammalian target of rapamycin (mTOR) signaling pathway implies an interesting potential as an anti-cancer agent [29]. The gene discussed is MTOR; the disease is polycystic ovary syndrome.